On Wednesday, Oct. 18, 2023, Cardiometabolic Health Congress (CMHC) returned to the Boston Park Plaza for the 18th Annual Conference, Social Determinants and Digital Advances
This clinical brief was developed from a session at the 17th Annual Cardiometabolic Health Congress (CMHC) presented by Irl B Hirsch, MD from the University
This clinical brief was developed by Cardiometabolic Health Congress (CMHC) and supported by an educational grant from Alnylam Pharmaceuticals, Inc. Click Here to claim up
Semaglutide and tirzepatide are some drugs developed for glucose control in diabetes that are now being used to treat obesity.
This complimentary activity was developed by Neha Agarwal, PhD, Senior Clinical Manager for Cardiometabolic Health Congress (CMHC). It is supported by an educational grant from Lilly
A recent report released by the American Medical Association (AMA) Council on Science and Public Health evaluated the problematic history of using body mass index
The U.S. Food and Drug Administration (FDA) announced on May 26, 2023, it had approved the once-daily oral tablet sotagliflozin to reduce the risk of
A peer-reviewed study circulated by the Journal of the American Medical Association on Monday, May 22, 2023, took a closer look at study results first
Compared with their nonpregnant counterparts, pregnant women with COVID-19 experience a more severe disease course with increased rates of intensive care unit admission and need
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.